Patient Guide: A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 59 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06433752
Status: 🟢 Enrolling Now
Condition: Relapsing Multiple Sclerosis, Multiple Sclerosis
Phase: Not Specified

Where You Can Participate

This study is available at 59 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Gilbert, Arizona
  • • Phoenix, Arizona
  • • And 56 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS) - Join Clinical Trial NCTNCT06433752

How to Join This Clinical Trial - NCTNCT06433752

Learn how to participate in this Not Specified trial studying an investigational therapy for Relapsing Multiple Sclerosis, Multiple Sclerosis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Relapsing Multiple Sclerosis, Multiple Sclerosis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Relapsing Multiple Sclerosis, Multiple Sclerosis
Treatment Being Tested
Investigational treatment
Study Phase
Not Specified - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06433752 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 59 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35209 - United States

Status: RECRUITING

Clinical Research Site

Gilbert, Arizona 85297 - United States

Status: RECRUITING

Clinical Research Site

Phoenix, Arizona 85032 - United States

Status: RECRUITING

Clinical Research Site

Newport Beach, California 92663 - United States

Status: RECRUITING

Clinical Research Site

Aurora, Colorado 80045 - United States

Status: RECRUITING

Clinical Research Site

Basalt, Colorado 81621 - United States

Status: RECRUITING

Clinical Research Site

Colorado Springs, Colorado 80918 - United States

Status: RECRUITING

Clinical Research Site

Denver, Colorado 80222 - United States

Status: RECRUITING

Clinical Research Site

Fort Collins, Colorado 80528 - United States

Status: RECRUITING

Clinical Research Site

Farmington, Connecticut 06032 - United States

Status: RECRUITING

And 49 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Not Specified clinical trial for Relapsing Multiple Sclerosis, Multiple Sclerosis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships